Armstrong WT - Search Results

1

Intensive lifestyle changes for reversal of coronary heart disease.

Ornish D, Scherwitz LW, Billings JH, Brown SE, Gould KL, Merritt TA, Sparler S, Armstrong WT, Ports TA, Kirkeeide RL, Hogeboom C, Brand RJ. Ornish D, et al. Among authors: armstrong wt. JAMA. 1998 Dec 16;280(23):2001-7. doi: 10.1001/jama.280.23.2001. JAMA. 1998. PMID: 9863851 Clinical Trial.

2

Improved stenosis geometry by quantitative coronary arteriography after vigorous risk factor modification.

Gould KL, Ornish D, Kirkeeide R, Brown S, Stuart Y, Buchi M, Billings J, Armstrong W, Ports T, Scherwitz L. Gould KL, et al. Am J Cardiol. 1992 Apr 1;69(9):845-53. doi: 10.1016/0002-9149(92)90781-s. Am J Cardiol. 1992. PMID: 1550011 Clinical Trial.

3

Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial.

Ornish D, Brown SE, Scherwitz LW, Billings JH, Armstrong WT, Ports TA, McLanahan SM, Kirkeeide RL, Brand RJ, Gould KL. Ornish D, et al. Among authors: armstrong wt. Lancet. 1990 Jul 21;336(8708):129-33. doi: 10.1016/0140-6736(90)91656-u. Lancet. 1990. PMID: 1973470 Clinical Trial.

4

Lifestyle changes and heart disease.

Ornish D, Brown SE, Scherwitz LW, Billings JH, Armstrong WT, Ports TA, McLanahan SM, Kirkeeide RL, Brand RJ, Gould KL. Ornish D, et al. Among authors: armstrong wt. Lancet. 1990 Sep 22;336(8717):741-2. doi: 10.1016/0140-6736(90)92230-f. Lancet. 1990. PMID: 1975906 No abstract available.

5

Changes in myocardial perfusion abnormalities by positron emission tomography after long-term, intense risk factor modification.

Gould KL, Ornish D, Scherwitz L, Brown S, Edens RP, Hess MJ, Mullani N, Bolomey L, Dobbs F, Armstrong WT, et al. Gould KL, et al. Among authors: armstrong wt. JAMA. 1995 Sep 20;274(11):894-901. doi: 10.1001/jama.1995.03530110056036. JAMA. 1995. PMID: 7674504 Clinical Trial.

6

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group. RECOVERY Collaborative Group. Lancet Child Adolesc Health. 2024 Mar;8(3):190-200. doi: 10.1016/S2352-4642(23)00316-4. Epub 2024 Jan 22. Lancet Child Adolesc Health. 2024. PMID: 38272046 Free article. Clinical Trial.

7

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group. RECOVERY Collaborative Group. Lancet Diabetes Endocrinol. 2023 Dec;11(12):905-914. doi: 10.1016/S2213-8587(23)00253-X. Epub 2023 Oct 18. Lancet Diabetes Endocrinol. 2023. PMID: 37865101 Free PMC article. Clinical Trial.

8

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.

RECOVERY Collaborative Group. RECOVERY Collaborative Group. Lancet. 2022 Jul 30;400(10349):359-368. doi: 10.1016/S0140-6736(22)01109-6. Lancet. 2022. PMID: 35908569 Free PMC article.

9

Acquired-cell immune deficiency syndrome.

Heidelman JF, Armstrong W, Graham L. Heidelman JF, et al. Oral Surg Oral Med Oral Pathol. 1983 May;55(5):452-3. doi: 10.1016/0030-4220(83)90228-1. Oral Surg Oral Med Oral Pathol. 1983. PMID: 6575333 No abstract available.

10

The use of the digital computer in the study of patients during exercise-induced stress.

Elliott SE, Miller CW, Armstrong WT Jr, Osborn JJ. Elliott SE, et al. Among authors: armstrong wt jr. Am Heart J. 1970 Feb;79(2):215-22. doi: 10.1016/0002-8703(70)90311-x. Am Heart J. 1970. PMID: 4903770 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page